Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Vaccine crawled date : 2020 - 12 - 03 save search
INOVIO Expands Global Manufacturing Consortium For Its COVID-19 Vaccine Candidate INO-4800 With Addition of Kaneka Eurogentec S.A.
Published: 2020-12-03 (Crawled : 15:00) - biospace.com/
INO 3 d | $10.22 -7.68% -8.32% 400K
|
Health Technology
|
| O: 2.29%
H: 9.28%
C: 2.25%
covid vaccine ino-4800
Vaxart’s COVID-19 Vaccine Selected for the U.S. Government’s Operation Warp Speed
Published: 2020-06-26 (Crawled : 09:36) - globenewswire.com
VXRT | $0.836 -3.48% -3.6% 880K
|
Health Technology
|
| O: 83.55%
H: 24.46%
C: -30.03%
covid vaccine covid-19
Vaxart Announces IND Filed for COVID-19 Vaccine
Published: 2020-08-10 (Crawled : 09:36) - globenewswire.com
VXRT | $0.836 -3.48% -3.6% 880K
|
Health Technology
|
| O: 4.57%
H: 2.6%
C: -2.24%
covid vaccine covid-19
Vaxart’s Oral COVID-19 Vaccine Candidate Induces Potent Systemic and Mucosal Immune Responses in Preclinical Studies
Published: 2020-09-08 (Crawled : 09:36) - globenewswire.com
VXRT | $0.836 -3.48% -3.6% 880K
|
Health Technology
|
| O: 12.37%
H: 2.71%
C: -13.0%
covid vaccine preclinical response covid-19 pre-clinical
Vaxart Announces FDA Clearance of IND Application for Oral COVID-19 Vaccine and Provides Update on COVID-19 Program
Published: 2020-09-14 (Crawled : 09:36) - globenewswire.com
VXRT | $0.836 -3.48% -3.6% 880K
|
Health Technology
|
| O: 20.38%
H: 32.76%
C: 21.94%
covid fda clearance fda vaccine covid-19 application clearance
Vaxart Announces Dosing First Subject in Phase 1 Clinical Trial of Its Oral Tablet COVID-19 Vaccine
Published: 2020-10-13 (Crawled : 09:36) - globenewswire.com
VXRT | $0.836 -3.48% -3.6% 880K
|
Health Technology
|
| O: 5.11%
H: 13.77%
C: 3.51%
covid vaccine trial phase 3 phase 1 phase 2
Vaxart Announces Positive Hamster Challenge Study Data for its Oral COVID-19 Vaccine
Published: 2020-10-14 (Crawled : 09:36) - globenewswire.com
VXRT | $0.836 -3.48% -3.6% 880K
|
Health Technology
|
| O: -0.78%
H: 2.1%
C: -9.33%
covid positive vaccine covid-19
Vaxart Announces Additional Data from Hamster Challenge Study of its Oral COVID-19 Vaccine
Published: 2020-11-12 (Crawled : 09:36) - globenewswire.com
VXRT | $0.836 -3.48% -3.6% 880K
|
Health Technology
|
| O: 12.7%
H: 8.86%
C: 2.31%
covid vaccine covid-19
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.